Skip over navigation

News & Events

Newsroom


	Pioneering biotherapeutics trial paves the way for innovative approaches to treat pulmonary arterial hypertension June 20, 2025 - Pulmonary arterial hypertension (PAH) is a rare and deadly disease that involves progressive damage to the tiny blood vessels that feed the lungs. In most cases, the cause is unknown and treatments are limited.


	Dr. Bernard Thébaud awarded $1.75M for research to help infants with lung disease June 20, 2025 - Dr. Bernard Thébaud has been awarded two grants from the Stem Cell Network to advance the development of cell- and gene-based approaches to treat infants with lung diseases.


	How to use audit and feedback to improve patient care June 20, 2025 - Audit and feedback is one of the most effective ways to support practice change in health care and improve patient care, but it doesn’t always work perfectly. To understand how audit and feedback is most likely to succeed, an international team ...


	Intravenous fluid study illustrates powerful, efficient approach for comparative clinical trials June 12, 2025 - A clinical trial led by researchers at The Ottawa Hospital and the University of Ottawa and published in the New England Journal of Medicine illustrates a powerful and efficient approach for comparing different standard treatments.


	Dr. Mark Freedman receives Giants of Multiple Sclerosis award June 12, 2025 - Dr. Mark Freedman has received the international Giants of Multiple Sclerosis Award for his groundbreaking research and unwavering dedication to the field

See all news items \| See only press releases \| Search for news and experts by disease / specialty

Media contacts

Jennifer Ganton
Director, Communications and Public Relations,
613-614-5253
jganton@ohri.ca